Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue sup1: Effectiveness of secukinumab in moderate-severe psoriasis and psoriatic arthritis: evidences from real-life experiences
Submit an article Journal homepage
163
Views
5
CrossRef citations to date
0
Altmetric
Efficacy of secukinumab on Psoriasis: evidences from real life experiences

Secukinumab for plaque psoriasis with ocular comorbidity: a clinical experience

Serafinella P. CannavòDermatology Clinic, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; View further author information
,
Elisa PostorinoEye Clinic Department of Biomedical Sciences, University of Messina, Messina, Italy; View further author information
,
Emanuela AragonaEye Clinic Department of Biomedical Sciences, University of Messina, Messina, Italy; View further author information
,
Annunziata BartolottaDermatology Clinic, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; View further author information
,
Valeria PapaianniDermatology Clinic, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; View further author information
&
Claudio GuarneriDepartment of Biomedical and Dental Sciences and Morpho Functional Imaging, University of Messina, Messina, ItalyCorrespondence[email protected]
View further author information
Pages 9-11 | Received 24 Apr 2018, Accepted 27 Jul 2018, Published online: 21 Dec 2018

References

  • Campanati A, Neri P, Giuliodori K, et al. Psoriasis beyond the skin surface: a pilot study on the ocular involvement. Int Ophthalmol. 2015;35:331–340.
  • Burden-Teh E, Murphy R. Psoriasis and uveitis-should we be asking about eye symptoms? Br J Dermatol. 2014;170:756–757.
  • Her Y, Lim JW, Han SH. Dry eye and tear film functions in patients with psoriasis. Jpn J Ophthalmol. 2013;57:341–346.
  • Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. 2007;5(2):108–152.
  • Aragona P, Cannavò SP, Borgia F, et al. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial. Br J Dermatol. 2005;152:576–578.
  • Fenga C, Aragona P, Di Nola C, et al. Comparison of ocular surface disease index and tear osmolarity as markers of ocular surface dysfunction in video terminal display workers. Am J Ophthalmol. 2014;158:41–48.
  • Armstrong AW, Papp K, Kircik L. Secukinumab: review of clinical evidence from the pivotal studies ERASURE, FIXTURE, and CLEAR. J Clin Aesthet Dermatol. 2016;9:S7–S12.
  • Menter A, Cather JC, Jarratt M, et al. Efficacy of secukinumab on moderate-to-severe plaque psoriasis affecting different body regions: a pooled analysis of four phase 3 studies. Dermatol Ther (Heidelb). 2016;6:639–647.
  • Elewski BE, Puig L, Mordin M, et al. Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab. J Dermatolog Treat. 2017;7:1–8.
  • Letko E, Yeh S, Foster CS, AIN457A2208 Study Group, et al. Efficacy and safety of intravenous secukinumab in non-infectious uveitis requiring steroid-sparing immunosuppressive therapy. Ophthalmology. 2015;122:939–948.
  • Hong J, Liu Z, Sun X, et al. Secukinumab in the treatment of noninfectious uveitis. Ophthalmology. 2013;120:e86.
  • Dick AD, Tugal-Tutkun I, Foster S, et al. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology. 2013;120:777–787.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.